Invesco’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,700
Closed -$425K 3903
2020
Q4
$425K Hold
2,700
﹤0.01% 3275
2020
Q3
$402K Sell
2,700
-100
-4% -$14.8K ﹤0.01% 3206
2020
Q2
$393K Hold
2,800
﹤0.01% 3242
2020
Q1
$367K Sell
2,800
-300
-10% -$42.6K ﹤0.01% 3182
2019
Q4
$453K Buy
3,100
+200
+7% +$27.1K ﹤0.01% 3294
2019
Q3
$376K Buy
2,900
+400
+16% +$52.7K ﹤0.01% 3356
2019
Q2
$349K Buy
2,500
+500
+25% +$69.2K ﹤0.01% 3445
2019
Q1
$280K Buy
2,000
+1,800
+900% +$241K ﹤0.01% 3511
2018
Q4
$26K Buy
+200
New +$27.9K ﹤0.01% 3746
2018
Q3
Sell
-2,800
Closed -$340K 3902
2018
Q2
$340K Hold
2,800
﹤0.01% 3560
2018
Q1
$359K Buy
+2,800
New +$378K ﹤0.01% 3448

Other funds holding JNJ

Invesco's JNJ Position: Q1 2026 in Review

Invesco increased its Johnson & Johnson (JNJ) stake by 18% in Q1 2026, buying an estimated $541M and bringing the position to 15,046,905 shares worth $3.68B. The position accounts for 0.36% of the portfolio, ranked #37.

Invesco first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Invesco held 15,046,905 shares of Johnson & Johnson worth $3.68B as of Q1 2026.
  • Invesco bought 2,321,024 Johnson & Johnson shares in Q1 2026, an estimated $541M.
  • Johnson & Johnson made up 0.36% of Invesco's portfolio in Q1 2026, its #37 holding.
  • Invesco first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.